ArticleJCO global oncology2023

Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India.

Dharna Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.